Increased atherosclerosis in LDL receptor-null mice lacking ACAT1 in macrophages.

During atherogenesis, circulating macrophages migrate into the subendothelial space, internalize cholesterol-rich lipoproteins, and become foam cells by progressively accumulating cholesterol esters. The inhibition of macrophage acyl coenzyme A:cholesterol acyltransferase (ACAT), which catalyzes the formation of cholesterol esters, has been proposed as a strategy to reduce foam cell formation and to treat atherosclerosis. We show here, however, that hypercholesterolemic LDL receptor-deficient (LDLR(-/-)) mice reconstituted with ACAT1-deficient macrophages unexpectedly develop larger atherosclerotic lesions than control LDLR(-/-) mice. The ACAT1-deficient lesions have reduced macrophage immunostaining and more free cholesterol than control lesions. Our findings suggest that selective inhibition of ACAT1 in lesion macrophages in the setting of hyperlipidemia can lead to the accumulation of free cholesterol in the artery wall, and that this promotes, rather than inhibits, lesion development.

[1]  Robert V Farese,et al.  Immunological quantitation and localization of ACAT-1 and ACAT-2 in human liver and small intestine. , 2000, The Journal of biological chemistry.

[2]  P. M. Yao,et al.  Free Cholesterol Loading of Macrophages Induces Apoptosis Involving the Fas Pathway* , 2000, The Journal of Biological Chemistry.

[3]  S. Perrey,et al.  Absence of ACAT-1 Attenuates Atherosclerosis but Causes Dry Eye and Cutaneous Xanthomatosis in Mice with Congenital Hyperlipidemia* , 2000, The Journal of Biological Chemistry.

[4]  H. Brewer.  The lipid-laden foam cell: an elusive target for therapeutic intervention. , 2000, The Journal of clinical investigation.

[5]  Robert V Farese,et al.  Massive xanthomatosis and altered composition of atherosclerotic lesions in hyperlipidemic mice lacking acyl CoA:cholesterol acyltransferase 1. , 2000, The Journal of clinical investigation.

[6]  P. Yancey,et al.  Crystallization of free cholesterol in model macrophage foam cells. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[7]  M. Linton,et al.  Macrophage lipoprotein lipase promotes foam cell formation and atherosclerosis in vivo. , 1999, The Journal of clinical investigation.

[8]  M C Phillips,et al.  Cell cholesterol efflux: integration of old and new observations provides new insights. , 1999, Journal of lipid research.

[9]  C. Glass,et al.  Paradoxical effect on atherosclerosis of hormone-sensitive lipase overexpression in macrophages. , 1999, Journal of lipid research.

[10]  J. Sawyer,et al.  Dietary monounsaturated fatty acids promote aortic atherosclerosis in LDL receptor-null, human ApoB100-overexpressing transgenic mice. , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[11]  J. Billheimer,et al.  Characterization of Two Human Genes Encoding Acyl Coenzyme A:Cholesterol Acyltransferase-related Enzymes* , 1998, The Journal of Biological Chemistry.

[12]  B. R. Krause,et al.  ACAT-2, A Second Mammalian Acyl-CoA:Cholesterol Acyltransferase , 1998, The Journal of Biological Chemistry.

[13]  G. S. Shelness,et al.  Identification of a Form of Acyl-CoA:Cholesterol Acyltransferase Specific to Liver and Intestine in Nonhuman Primates* , 1998, The Journal of Biological Chemistry.

[14]  S. Horiuchi,et al.  Expression of ACAT-1 protein in human atherosclerotic lesions and cultured human monocytes-macrophages. , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[15]  G. Melino,et al.  Cholesterol, but not its esters, triggers programmed cell death in human erythroleukemia K562 cells. , 1998, European journal of biochemistry.

[16]  R. Nicolosi,et al.  The ACAT inhibitor, CI-1011 is effective in the prevention and regression of aortic fatty streak area in hamsters. , 1998, Atherosclerosis.

[17]  D. Small,et al.  Effects of intracellular free cholesterol accumulation on macrophage viability: a model for foam cell death. , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[18]  Robert V Farese,et al.  Tissue expression studies on the mouse acyl-CoA: cholesterol acyltransferase gene (Acact): findings supporting the existence of multiple cholesterol esterification enzymes in mice. , 1997, Journal of lipid research.

[19]  M. Linton,et al.  Increased atherosclerosis in mice reconstituted with apolipoprotein E null macrophages. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[20]  Robert V Farese,et al.  Disruption of the acyl-CoA:cholesterol acyltransferase gene in mice: evidence suggesting multiple cholesterol esterification enzymes in mammals. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[21]  Matthew A. Thomas,et al.  Regulation and Immunolocalization of Acyl-Coenzyme A:Cholesterol Acyltransferase in Mammalian Cells as Studied with Specific Antibodies (*) , 1995, The Journal of Biological Chemistry.

[22]  F. Ito,et al.  Effect of FR145237, a novel ACAT inhibitor, on atherogenesis in cholesterol-fed and WHHL rabbits. Evidence for a direct effect on the arterial wall. , 1995, Biochimica et biophysica acta.

[23]  C. Chang,et al.  Tissue-specific Expression and Cholesterol Regulation of Acylcoenzyme A:Cholesterol Acyltransferase (ACAT) in Mice , 1995, The Journal of Biological Chemistry.

[24]  E M Rubin,et al.  Quantitation of atherosclerosis in murine models: correlation between lesions in the aortic origin and in the entire aorta, and differences in the extent of lesions between sexes in LDL receptor-deficient and apolipoprotein E-deficient mice. , 1995, Journal of lipid research.

[25]  O. Press,et al.  Translocation of Ricin A-chain into Proteoliposomes Reconstituted from Golgi and Endoplasmic Reticulum (*) , 1995, The Journal of Biological Chemistry.

[26]  J. Skepper,et al.  Evidence that the death of macrophage foam cells contributes to the lipid core of atheroma. , 1995, Atherosclerosis.

[27]  W. J. Johnson,et al.  Cell Toxicity Induced by Inhibition of Acyl Coenzyme A:Cholesterol Acyltransferase and Accumulation of Unesterified Cholesterol * , 1995, The Journal of Biological Chemistry.

[28]  J. Dreesen,et al.  Diagnosing and preventing inherited disease: Multiplex polymerase chain reaction for sex determination of single mouse blastomeres , 1995 .

[29]  S. Fazio,et al.  Prevention of atherosclerosis in apolipoprotein E-deficient mice by bone marrow transplantation , 1995, Science.

[30]  J. Touraine,et al.  Comparison of fresh, cryopreserved and cultured haematopoietic stem cells from fetal liver. , 1994, Bone marrow transplantation.

[31]  D K Burns,et al.  Massive xanthomatosis and atherosclerosis in cholesterol-fed low density lipoprotein receptor-negative mice. , 1994, The Journal of clinical investigation.

[32]  Koyo. Matsuda.  ACAT inhibitors as antiatherosclerotic agents: Compounds and mechanisms , 1994, Medicinal research reviews.

[33]  K. Cadigan,et al.  Molecular cloning and functional expression of human acyl-coenzyme A:cholesterol acyltransferase cDNA in mutant Chinese hamster ovary cells. , 1993, The Journal of biological chemistry.

[34]  S. Fazio,et al.  Type III hyperlipoproteinemic phenotype in transgenic mice expressing dysfunctional apolipoprotein E. , 1993, The Journal of clinical investigation.

[35]  R. Hammer,et al.  Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery. , 1993, The Journal of clinical investigation.

[36]  N. Maeda,et al.  Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. , 1992, Science.

[37]  T. Bocan,et al.  Comparison of CI-976, an ACAT inhibitor, and selected lipid-lowering agents for antiatherosclerotic activity in iliac-femoral and thoracic aortic lesions. A biochemical, morphological, and morphometric evaluation. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.

[38]  V. Babaev,et al.  Identification of intimal subendothelial cells from human aorta in primary culture. , 1988, Atherosclerosis.

[39]  R. Williams,et al.  Quantitative assessment of atherosclerotic lesions in mice. , 1987, Atherosclerosis.

[40]  B. Craven,et al.  Crystal structure of cholesterol monohydrate , 1976, Nature.

[41]  Russell Hk,et al.  A modification of Movat's pentachrome stain. , 1972 .

[42]  Movat Hz.  Demonstration of all connective tissue elements in a single section; pentachrome stains. , 1955 .

[43]  T. Major,et al.  The ACAT inhibitor avasimibe reduces macrophages and matrix metalloproteinase expression in atherosclerotic lesions of hypercholesterolemic rabbits. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[44]  T. Chang,et al.  Acyl-coenzyme A:cholesterol acyltransferase. , 1997, Annual review of biochemistry.

[45]  D. Sliskovic,et al.  Therapeutic potential of ACAT inhibitors as lipid lowering and anti-atherosclerotic agents. , 1991, Trends in pharmacological sciences.

[46]  M. Brown,et al.  Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis. , 1983, Annual review of biochemistry.

[47]  H. Movat,et al.  Demonstration of all connective tissue elements in a single section; pentachrome stains. , 1955, A.M.A. archives of pathology.